Download your poster on analysis of insulino-secreter and anti-apoptotic compounds in type 2 diabetes

Multi parameter approach to your study

Insulin secretion triggered by glucose is potentiated by the activation of receptors coupled to G proteins (Galphas) (RCPGs), such as the GLP-1 (RGLP-1) or GPR-119 receptors. The agonists of these receptors have been widely studied for treating type 2 diabetes. In order to better characterize and compare the insulinosecretor and/or antiapoptotic abilities of these receptor agonists, we have developed a new multi-parametric approach based on HTRF technology and which enables key parameters to be followed simultaneously: insulin secretion, the production of second messengers (cAMP), and the activation of survival transcription factors, such as CREB (cAMP-responsive element binding protein), by phosphorylation.

 Download poster

 

flyer-poster_insulino-secreter and anti-apoptotic compounds-1

Insulin Guide: the next level in insulin quantification

Download Insulin guide

Cisbio offers a comprehensive line of insulin quantification assays designed to significantly reduce the time to results, sample consumption and cost of quantifying insulin. This brochure describes the functionality and benefits of all 3 assay kits available for insulin quantification.